Roundhill GLP-1 & Weight Loss ETF Rating $25.55 +0.83 (+3.36%) As of 05/2/2025 03:47 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.72Holdings in OZEM have an aggregate rating of Moderate Buy based on 208 analyst ratings issued in the past year covering 15 companies (69.1% of the portfolio).OZEM Aggregate Price Target$25.55High Prediction$25.55Average Prediction$25.55Low Prediction$25.55Holdings in OZEM have an aggregate price target of $25.55 and a range of $25.55 to $25.55 covering 15 companies (69.1% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.03%NVONovo Nordisk A/S$69.27+5.6%4.7184 of 5 stars2.38$135.00 94.9%13Upcoming EarningsShort Interest ↑Gap UpHigh Trading Volume15.17%LLYEli Lilly and Company$825.10+3.9%4.9397 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up4.64%GPCRStructure Therapeutics$27.09-0.9%2.4351 of 5 stars3.00$78.63 190.2%9Upcoming EarningsAnalyst ForecastNews CoverageGap Up4.20%VKTXViking Therapeutics$29.36+2.6%4.5286 of 5 stars3.00$87.15 196.8%14Analyst UpgradeOptions VolumeAnalyst RevisionGap Up3.61%ALTAltimmune$5.77+11.6%2.547 of 5 stars3.00$20.83 261.1%8Upcoming EarningsNews CoveragePositive News3.54%PFEPfizer$24.19+1.1%4.9849 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst ForecastAnalyst Revision3.15%AZNAstraZeneca$72.44+2.7%2.9283 of 5 stars3.10$88.00 21.5%10Earnings ReportShort Interest ↓Analyst RevisionPositive News3.12%AMGNAmgen$281.22-0.9%4.0942 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up2.72%TERNTerns Pharmaceuticals$3.50-1.7%4.2725 of 5 stars2.60$18.38 425.0%5News CoveragePositive News2.29%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8364 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume2.15%SRRKScholar Rock$32.91+0.5%4.0621 of 5 stars3.00$42.67 29.6%6Upcoming EarningsInsider TradeNews CoveragePositive NewsGap Down1.81%GILDGilead Sciences$103.68+0.4%4.7892 of 5 stars2.78$110.55 6.6%27Dividend Announcement1.77%BHVNBiohaven$22.76+1.4%3.7843 of 5 stars3.07$62.54 174.8%15Upcoming EarningsGap Up1.68%RYTMRhythm Pharmaceuticals$64.01+0.3%3.7807 of 5 stars3.00$74.92 17.0%13Upcoming EarningsInsider Trade1.23%OPKOPKO Health$1.39+2.6%4.4861 of 5 stars2.75$2.75 98.6%4Earnings ReportAnalyst ForecastAnalyst RevisionPositive News This page (NASDAQ:OZEM) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OZEM Stock Free OZEM Stock Alerts